Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 20, 2015The Journal of ImmunologyOpen Access

Landscape of Tumor Antigens in T Cell Immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

SISadia IlyasUniversity of California, San Diego
James Chih‐Hsin Yang
James Chih‐Hsin YangAstraZeneca (United Kingdom)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ilyas et al. (2015) studied this question.

synapsesocial.com/papers/6a7d64592d005ba2c41cd487https://doi.org/10.4049/jimmunol.1501657
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence2007 · 754 citations
  2. 2Cancer/testis (CT) antigens: Potential targets for immunotherapy2009 · 557 citations
  3. 3Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity2013 · 720 citations
  4. 4Production of stable cytolytic T‐cell clones directed against autologous human melanoma1987 · 209 citations
  5. 5Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab2015 · 449 citations